Developer docs
API playgroundTry for free, no card

Search company profiles

Bioverge

Full company profile

uuid003fnvo

Namestring
Bioverge
Legal namestring
Bioverge, Inc.
Websiteurl
bioverge.com
Company typeenum
Private
Founded yearint
2016
Short descriptiontext

Bioverge is a fintech investment platform that uses AI-driven diligence to curate healthcare and biotech startup offerings for individual investors via Regulation Crowdfunding on Republic.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
healthcare startup investing, biotech venture capital, AI due diligence, regulation crowdfunding, startup investment platform
Product category
Healthcare Investment Platform
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Investment Platform Fees
TypeTransaction Fee
Description

Bioverge operates as a fintech investment platform that likely generates revenue through transaction fees or platform fees associated with Regulation Crowdfunding investment rounds on its platform. The company completed a Reg CF offering in August 2023 raising between $624,999.99 and $1,235,000.

republic.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Core offering1 text field

Bioverge is a fintech investment platform that democratizes access to early-stage healthcare and biotech startup investments. The platform leverages AI-driven diligence to evaluate and score healthcare investment opportunities, and uses Regulation Crowdfunding (via Republic) to enable both accredited and non-accredited individual investors to participate alongside the firm in funding healthcare and biomedical startups.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Bioverge Platform
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Peers10 records
1SeedInvest
TypeBroad incumbent
Description

Equity crowdfunding platform offering Reg CF and Reg D access to retail and accredited investors, directly comparable in deal-structuring mechanics but with a broader sector mandate than Bioverge.

2MicroVentures
TypeDirect peer
Description

Smaller equity crowdfunding platform operating under Reg CF and Reg A+ with comparable per-deal transaction economics to Bioverge, though without healthcare specialization.

3AngelList (now AngelList Venture)
TypeBroad incumbent
Description

Platform connecting startups with investors via funds, syndicates, and rolling funds; overlaps with Bioverge in facilitating access to early-stage startup investment, but with a stronger orientation toward accredited investors and venture funds.

4Republic
TypeDirect peer
Description

Regulation Crowdfunding platform that is Bioverge's core distribution partner and a direct comparable in retail-access private-market investing; offers a similar per-deal, retail-investor-facing model across multiple sectors including healthcare.

5Seedrs
TypeRegional player
Description

European equity crowdfunding platform with comparable retail-investor mechanics to Bioverge, though operating primarily in the UK/EU rather than the U.S. Reg CF market.

6StartEngine
TypeBroad incumbent
Description

Major equity crowdfunding platform (Reg CF and Reg A+) that competes with Bioverge for issuer mindshare and retail investor capital across all sectors, with substantially greater scale and capital.

7Crowdcube
TypeRegional player
Description

UK-based equity crowdfunding platform comparable in business model (retail-access private placement) but operating in a different regulatory geography than Bioverge's U.S. Reg CF positioning.

8Wefunder
TypeBroad incumbent
Description

One of the largest U.S. equity crowdfunding platforms under Reg CF and Reg A+, offering a comparable retail-investor model but across a much broader set of issuers than Bioverge's healthcare-only focus.

9OurCrowd
TypeDirect peer
Description

Global equity crowdfunding platform with a notable healthcare and biotech vertical, making it the closest sector-specialized comparable to Bioverge's healthcare-narrow positioning.

10DealMaker
TypeBroad incumbent
Description

Tech-enabled securities issuance platform supporting Reg CF, Reg A+, and Reg D campaigns — comparable to the technology layer Bioverge uses through Republic, but serving a broader range of issuers directly.

Market position
Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment54 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bioverge

Healthcare Investment Platformbioverge.com

Bioverge is a fintech investment platform that uses AI-driven diligence to curate healthcare and biotech startup offerings for individual investors via Regulation Crowdfunding on Republic.

Bioverge firmographics

Firmographics
Name
Bioverge
Legal name
Bioverge, Inc.
Website
https://bioverge.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
Bioverge is a fintech investment platform that uses AI-driven diligence to curate healthcare and biotech startup offerings for individual investors via Regulation Crowdfunding on Republic.
Ownership category
akta.pro rank

Where Bioverge is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Markets served

Bioverge business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Investment Platform Fees: Bioverge operates as a fintech investment platform that likely generates revenue through transaction fees or platform fees associated with Regulation Crowdfunding investment rounds on its platform. The company completed a Reg CF offering in August 2023 raising between $624,999.99 and $1,235,000.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Bioverge product offering

Product offering

Core offering

Bioverge is a fintech investment platform that democratizes access to early-stage healthcare and biotech startup investments. The platform leverages AI-driven diligence to evaluate and score healthcare investment opportunities, and uses Regulation Crowdfunding (via Republic) to enable both accredited and non-accredited individual investors to participate alongside the firm in funding healthcare and biomedical startups.

Differentiator

Problem solved

Functional benefit

Products and services

  • Bioverge Platform

Companies that use Bioverge

Customer profile

Segments2 records

Ideal customer profiles2 records

Bioverge technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature1 record

Bioverge partnerships and signals

Strategic signal

Scale indicators2 records

Bioverge competitors and assessment

Company assessment

Broad incumbents

  • SeedInvest: Equity crowdfunding platform offering Reg CF and Reg D access to retail and accredited investors, directly comparable in deal-structuring mechanics but with a broader sector mandate than Bioverge.
  • AngelList (now AngelList Venture): Platform connecting startups with investors via funds, syndicates, and rolling funds; overlaps with Bioverge in facilitating access to early-stage startup investment, but with a stronger orientation toward accredited investors and venture funds.
  • StartEngine: Major equity crowdfunding platform (Reg CF and Reg A+) that competes with Bioverge for issuer mindshare and retail investor capital across all sectors, with substantially greater scale and capital.
  • Wefunder: One of the largest U.S. equity crowdfunding platforms under Reg CF and Reg A+, offering a comparable retail-investor model but across a much broader set of issuers than Bioverge's healthcare-only focus.
  • DealMaker: Tech-enabled securities issuance platform supporting Reg CF, Reg A+, and Reg D campaigns — comparable to the technology layer Bioverge uses through Republic, but serving a broader range of issuers directly.

Direct peers

  • MicroVentures: Smaller equity crowdfunding platform operating under Reg CF and Reg A+ with comparable per-deal transaction economics to Bioverge, though without healthcare specialization.
  • Republic: Regulation Crowdfunding platform that is Bioverge's core distribution partner and a direct comparable in retail-access private-market investing; offers a similar per-deal, retail-investor-facing model across multiple sectors including healthcare.
  • OurCrowd: Global equity crowdfunding platform with a notable healthcare and biotech vertical, making it the closest sector-specialized comparable to Bioverge's healthcare-narrow positioning.

Regional players

  • Seedrs: European equity crowdfunding platform with comparable retail-investor mechanics to Bioverge, though operating primarily in the UK/EU rather than the U.S. Reg CF market.
  • Crowdcube: UK-based equity crowdfunding platform comparable in business model (retail-access private placement) but operating in a different regulatory geography than Bioverge's U.S. Reg CF positioning.

Market position

Customer concentration

Bioverge social profiles

Digital presence

Bioverge financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bioverge leadership team

Management profile

Number of profiles

Profiles2 records

Bioverge funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bioverge M&A and investment

M&A and investment

M&A

Investments54 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioverge

What does Bioverge do?

Bioverge is a fintech investment platform that democratizes access to early-stage healthcare and biotech startup investments. The platform leverages AI-driven diligence to evaluate and score healthcare investment opportunities, and uses Regulation Crowdfunding (via Republic) to enable both accredited and non-accredited individual investors to participate alongside the firm in funding healthcare and biomedical startups.

Is Bioverge a public or private company?

Bioverge is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Bioverge founded?

Bioverge was founded in 2016. It employs 1 to 10 people.

Where is Bioverge based?

Bioverge is headquartered in San Francisco, United States, in the North America region.

How does Bioverge make money?

One revenue line is on record: investment Platform Fees.

Who are Bioverge's main competitors?

Broad incumbents on record are SeedInvest, AngelList (now AngelList Venture), StartEngine, Wefunder and DealMaker. Direct peers are MicroVentures, Republic and OurCrowd. Regional players are Seedrs and Crowdcube.

Does Bioverge have an API?

No public API is recorded for Bioverge.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinSMEsUberdoc Receives Investment From CharmHealth and BiovergeUberdoc, a Boston-based healthcare platform, received an undisclosed investment from CharmHealth and Bioverge. The company plans to use the funds to expand its network of 5,000 doctors across all 50 states and accelerate growth in new geographies.RepublicBiovergeBioverge, Inc. has closed a Regulation Crowdfunding offering hosted by Republic to raise capital for its fintech platform focused on healthcare and biotech investments. The campaign concluded on August 8, 2023, with the company raising between $624,999.99 and $1,235,000 depending on investor participation levels.FinSMEsMy Diabetes Tutor Receives Investment from CharmHealth and BiovergeMy Diabetes Tutor, a Hanford-based startup focused on diabetes education technology, has secured an undisclosed investment from CharmHealth and Bioverge. The company plans to utilize these funds for technology development, sales, and marketing to expand its reach among Americans with diabetes.GlobeNewswireMedicalMine Inc., the Host of CharmHealth.com, Announces the Formation of the CharmHealth + Bioverge Digital Transformation FundCharmHealth, through its CharmHealth + Bioverge Digital Transformation Fund, will invest in early-stage digital health companies. The fund is managed with Bioverge and aims to bridge the gap between innovation and end-user validation. It will leverage CharmHealth's platform to accelerate validation and de-risking.NetcapitalBioverge ← NetcapitalBioverge is raising up to $1.07 million through a Regulation Crowdfunding offering on the Netcapital platform to democratize access to its TechBio startup portfolio. The company highlights its track record of investing in 28 startups alongside major venture firms, citing strong unrealized returns and two notable exits since its inception in 2016. This offering aims to expand Bioverge's capabilities as both an online venture capital syndicator and a crowdfunding portal for non-accredited investors.PR NewswireBioverge Equity Crowdfunding Campaign Offers Everyone Access to the World's First-Ever Investment Platform Dedicated to the TechBio RevolutionBioverge, Inc. is launching an equity crowdfunding campaign to raise up to $5 million under Regulation CF, expanding access to its techbio investment platform beyond accredited investors. The company highlights a portfolio of 28 companies with two exits and notes that its model provides curated deals in computational biology, genomics, and digital health.PR NewswireBioverge, Inc. Launches an Equity Crowdfunding Platform Focused on Funding Innovative Healthcare Start-upsBioverge, Inc. has launched an equity crowdfunding platform called Bioverge Portal, designed to provide both accredited and non-accredited investors access to vetted private healthcare startups that have already attracted validation from professional healthcare investors. The platform will operate under Regulation CF rules, allowing companies to raise up to $5 million, with Bioverge planning its own Reg CF campaign to further develop the portal. Founded in 2016 and headquartered in San Francisco, Bioverge has built a portfolio of 23 companies and participated in 11 follow-on rounds, leveraging its network of healthcare specialists and functional experts to support scientific founders.